Baxa to Feature Exacta-Med and PhaSeal Systems for Safe Handling and Administration of Fluid Drugs at the Pharmaceutical Marketing Congress in Philadelphia.PHILADELPHIA -- At the third annual Pharmaceutical Marketing Congress, Baxa Corporation presents its proprietary systems designed to enhance the safety and efficiency of fluid medication delivery. The PhaSeal(R) System is the only closed system for handling antineoplastic antineoplastic /an·ti·neo·plas·tic/ (-ne?o-plas´tik) 1. inhibiting or preventing development of neoplasms; checking maturation and proliferation of malignant cells. 2. an agent that so acts. and other hazardous drugs In pharmacology, hazardous drugs are drugs that are known to cause , which is the ability to cause a change or mutation in genetic material; , the ability to cause cancer in animal models, humans or both; , which is the ability to cause defects on fetal development or fetal that has been documented to reduce or eliminate human exposure to toxic hazards in the workplace. PhaSeal products allow healthcare workers to reconstitute re·con·sti·tute tr.v. re·con·sti·tut·ed, re·con·sti·tut·ing, re·con·sti·tutes 1. To provide with a new structure: The parks commission has been reconstituted. 2. , transport and administer hazardous drugs without risk of environmental contamination. The Exacta-Med(R) System provides oral and enteral enteral /en·ter·al/ (en´ter'l) enteric. en·ter·al adj. 1. Within or by way of the intestine, as distinguished from parenteral. 2. Enteric. medication delivery without risk of wrong-route administration. The system's non-luer components cannot actuate a needleless valve or connect to a hypodermic needle hypodermic needle n. 1. A hollow needle used with a hypodermic syringe. 2. A hypodermic syringe including the needle. or fitting. Both PhaSeal and Exacta-Med products offer added value Added value in financial analysis of shares is to be distinguished from value added. Used as a measure of shareholder value, calculated using the formula:
The Pharmaceutical Marketing Congress, which continues through September 29, brings together business development and marketing executives to focus on strategic alliances, patient education and compliance, and market development issues. This year is the first for Baxa Corporation's participation in the event. Baxa offers a dedication to safety and efficiency for fluid medication handling and delivery that provides manufacturers a way to ensure delivery accuracy and differentiation for their drug products. Healthcare professionals have recognized Baxa products for their quality and design for thirty years. "With our participation in meetings such as this Congress, Baxa is looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. opportunities to help other manufacturers meet their goals -- whether they are creating new opportunities for mature products, or looking for systems to improve the outcomes of clinical trials," affirms Steve Welch, VP of New Business Development. "With thirty years' experience, Baxa has the regulatory background and market knowledge to assist other companies in the development of specialized products for drug delivery applications, or as a partner to add value through improved patient safety and compliance." Founded in 1975, Baxa Corporation built its reputation by designing niche products that provide solutions for the transfer, delivery, packaging and administration of fluid medications in hospital pharmacy and alternate-site settings worldwide. The company has achieved certification to the quality standards for ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 13485 and EN46001. About Baxa Corporation A leading provider of devices and systems for the preparation, handling, packaging and administration of liquid medications, Baxa manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Headquartered in Englewood, Colorado, Baxa has subsidiaries and sales offices in Canada, the United Kingdom; Denmark and Germany; and distribution partners worldwide. Further information is available at www.baxa.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion